Analysis of Tissue Factor Positive Microparticles

door Key, Nigel S.
Gepubliceerd in 2010

Current Treatment of Venous Thromboembolism

door Key, Nigel S., Kasthuri, Raj S.
Gepubliceerd in 2010

Medical Management of Venous Thromboembolism: What the Interventional Radiologist Needs to Know

door Kasthuri, Raj S., Key, Nigel S.
Gepubliceerd in 2012

How I treat patients with inherited bleeding disorders who need anticoagulant therapy

door Martin, Karlyn, Key, Nigel S.
Gepubliceerd in Blood (2016)

Sickle-Cell Trait: Novel Clinical Significance

door Key, Nigel S., Derebail, Vimal K.
Gepubliceerd in 2010

Microparticle Analysis in Disorders of Hemostasis and Thrombosis

door Mooberry, Micah J., Key, Nigel S.
Gepubliceerd in Cytometry A (2015)

Pregnancy in Sickle Trait: What we Know and What we Don’t

door Wilson, Samuel, Ellsworth, Patrick, Key, Nigel S.
Gepubliceerd in Br J Haematol (2020)

Negative Health Implications Of Sickle Cell Trait in High Income Countries: From The Football Field To The Laboratory

door Key, Nigel S., Connes, Philippe, Derebail, Vimal K.
Gepubliceerd in Br J Haematol (2015)

Coagulation Abnormalities of Sickle Cell Disease: Relationship with Clinical Outcomes and the Effect of Disease Modifying Therapies

door Noubouossie, Denis, Key, Nigel S., Ataga, Kenneth I.
Gepubliceerd in Blood Rev (2015)

Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis

door Gordeuk, Victor R., Key, Nigel S., Prchal, Josef T.
Gepubliceerd in Haematologica (2019)

Tissue Factor; from Morawitz to Microparticles

door Key, Nigel S., Geng, Jian-Guo, Bach, Ronald R
Gepubliceerd in 2007

Red blood cells and thrombin generation in sickle cell disease

door Whelihan, Matthew F., Lim, Ming Y., Key, Nigel S.
Gepubliceerd in 2014

Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria

door Lim, Ming Y., Volmar, Keith E., Key, Nigel S.
Gepubliceerd in Case Rep Hematol (2019)

The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues

door Campello, Elena, Ilich, Anton, Simioni, Paolo, Key, Nigel S.
Gepubliceerd in Br J Cancer (2019)

How to discuss gene therapy for haemophilia? A patient and physician perspective

door Miesbach, Wolfgang, O’Mahony, Brian, Key, Nigel S., Makris, Mike
Gepubliceerd in Haemophilia (2019)

Using heparin molecules to manage COVID‐2019

door Liu, Jian, Li, Jine, Arnold, Katelyn, Pawlinski, Rafal, Key, Nigel S.
Gepubliceerd in Res Pract Thromb Haemost (2020)

Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer

door Kasthuri, Raj S., Hisada, Yohei, Ilich, Anton, Key, Nigel S., Mackman, Nigel
Gepubliceerd in Res Pract Thromb Haemost (2020)

Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses

door Mackman, Nigel, Antoniak, Silvio, Wolberg, Alisa S., Kasthuri, Raj, Key, Nigel S.
Gepubliceerd in Arterioscler Thromb Vasc Biol (2020)

Neutrophils: back in the thrombosis spotlight

door Noubouossie, Denis F., Reeves, Brandi N., Strahl, Brian D., Key, Nigel S.
Gepubliceerd in Blood (2019)

De novo synthesis of a narrow size distribution low-molecular-weight heparin

door Chandarajoti, Kasemsiri, Xu, Yongmei, Sparkenbaugh, Erica, Key, Nigel S, Pawlinski, Rafal, Liu, Jian
Gepubliceerd in 2014